Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster

Journal of Psychiatry and Neuroscience

Volumn 37, Issue 5, 2012, Pages 313-321

  Kaur, Manreena ^a   Battisti, Robert A ^a   Lagopoulos, Jim ^a   Ward, Philip B ^b,c   Hickie, Ian B ^a   Hermens, Daniel F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EVENT RELATED POTENTIAL; FEMALE; HUMAN; MALE; MISMATCH NEGATIVITY; NEUROPSYCHOLOGY; PATHOPHYSIOLOGY; PSYCHOSIS; PSYCHOSOCIAL ENVIRONMENT; QUALITY OF LIFE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SKULL DISEASE;

EID: 84865846943     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.110081     Document Type: Article

References (53)

1. Goldberg DP, Andrews G, Hobbs MJ. Where should bipolar disorder appear in the meta-structure? Psychol Med 2009;39:2071-81.
2. Boks MPM, Leask S, Vermunt JK, et al. The structure of psychosis revisited: the role of mood symptoms. Schizophr Res 2007;93:178-85.
3. Berrettini WH. Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia. Biol Psychiatry 2000;47:245-51.
4. Lewis CM, Levinson DF, Wise LH, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003;73:34-48.
5. Burmeister M, McInnis MG, Zollner S. Psychiatric genetics: progress amid controversy. Nat Rev Genet 2008;9:527-40.
6. Lichtenstein P, Yip BH, Bjork C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009;373:234-9.
7. Javitt DC, Spencer KM, Thaker GK, et al. Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov 2008;7:68-83.
8. Näätänen R, Kahkonen S. Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review. Int J Neuropsychopharmacol 2009;12:125-35.
9. Turetsky BI, Bilker WB, Siegel SJ, et al. Profile of auditory information-processing deficits in schizophrenia. Psychiatry Res 2009;165:27-37.
10. Fisher DJ, Labelle A, Knott VJ. Auditory hallucinations and the P3a: attention-switching to speech in schizophrenia. Biol Psychol 2010;85:417-23.
11. Näätänen R. The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function. Behav Brain Sci 1990;13:201-88.
12. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007;118:2128-48.
13. Friedman D, Cycowicz YM, Gaeta H. The novelty P3: an event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neurosci Biobehav Rev 2001;25:355-73.
14. Light GA, Swerdlow NR, Braff DL. Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci 2007;19:1624-32.
15. Hermens DF, Ward PB, Redoblado Hodge MA, et al. Impaired MMN/P3a complex in first episode psychosis: cognitive and psychosocial associations. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:822-9.
16. Kaur M, Battisti RA, Ward PB, et al. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups. Schizophr Res 2011;130:203-9.
17. Catts SV, Shelley AM, Ward PB, et al. Brain potential evidence for an auditory sensory memory deficit in schizophrenia. Am J Psychiatry 1995;152:213-9.
18. Umbricht D, Koller R, Schmid L, et al. How specific are deficits in mismatch negativity generation to schizophrenia? Biol Psychiatry 2003;53:1120-31.
19. Salisbury DF, Kuroki N, Kasai K, et al. Progressive and inter-related functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry 2007;64:521-9.
20. Rasser PE, Schall U, Todd J, et al. Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull 2011;37: 131-40.
21. Todd J, Michie PT, Schall U, et al. Deviant matters: duration, frequency, and intensity deviants reveal different patterns of mis-match negativity reduction in early and late schizophrenia. Biol Psychiatry 2008;63:58-64.
22. Shelley AM, Ward PB, Catts SV, et al. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry 1991;30:1059-62.
23. Baldeweg T, Klugman A, Gruzelier J, et al. Mismatch negativity potentials and cognitive impairment in schizophrenia. Schizophr Res 2004;69:203-17.
24. Baldeweg T, Klugman A, Gruzelier JH, et al. Impairment in frontal but not temporal components of mismatch negativity in schizophrenia. Int J Psychophysiol 2002;43:111-22.
25. Hall MH, Schulze K, Rijsdijk F, et al. Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol Med 2009;39:1277-87.
26. Andersson S, Barder HE, Hellvin T, et al. Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder. Bipolar Disord 2008;10:888-99.
27. Scott E, Naismith S, Whitwell B, et al. Delivering youth-specific mental health services: the advantages of a collaborative, multi-disciplinary system. Australas Psychiatry 2009;17:189-94.
28. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2007.
29. Ventura J, Green MF, Shaner A, et al. Training and quality assurance with the Brief Psychiatric Rating Scale: the drift busters. Int J Methods Psychiatr Res 1993;3:221-4.
30. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
31. Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992;149: 1148-56.
32. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 1995;33:335-43.
33. Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A Report from the WHOQOL Group. Qual Life Res 2004;13:299-310.
34. Kim SJ, Lyoo IK, Hwang J, et al. Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology 2005;30:1383-91.
35. Semlitsch HV, Anderer P, Schuster P, et al. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 1986;23:695-703.
36. Delorme A. EEGLAB: an open source toolbox for analysis of single trial EEG dynamics. J Neurosci Methods 2004;134:9-21.
37. Wechsler D. Wechsler Test of Adult Reading. San Antonio (TX): Psychological Corporation; 2002.
38. Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. 3rd ed. New York: Oxford University Press; 2006.
39. Naätänen R, Kujala T, Winkler I. Auditory processing that leads to conscious perception: a unique window to central auditory processing opened by the mismatch negativity and related responses. Psychophysiology 2011;48:4-22.
40. Thönnessen H, Zvyagintsev M, Harke KC, et al. Optimized mis-match negativity paradigm reflects deficits in schizophrenia patients. A combined EEG and MEG study. Biol Psychol 2008;77: 205-16.
41. Youn T, Park H-J, Kim J-J, et al. Altered hemispheric asymmetry and positive symptoms in schizophrenia: equivalent current dipole of auditory mismatch negativity. Schizophr Res 2003;59:253-60.
42. Michie PT. What has MMN revealed about the auditory system in schizophrenia? Int J Psychophysiol 2001;42:177-94.
43. Umbricht D, Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 2005;76:1-23.
44. Takei Y, Kumano S, Hattori S, et al. Preattentive dysfunction in major depression: a magnetoencephalography study using auditory mismatch negativity. Psychophysiology 2009;46:52-61.
45. Bar-Haim Y, Marshall PJ, Fox NA, et al. Mismatch negativity in socially withdrawn children. Biol Psychiatry 2003;54:17-24.
46. Light GA, Braff DL. Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. Am J Psychiatry 2005;162:1741-3.
47. Light GA, Braff DL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry 2005;62:127-36.
48. Rasser PE, Schall U, Todd J, et al. Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull 2011;37: 131-40.
49. Korostenskaja M, Dapsys K, Siurkute A, et al. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:543-8.
50. Umbricht D, Javitt D, Novak G, et al. Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry 1998; 44:716-25.
51. Umbricht D, Javitt D, Novak G, et al. Effects of risperidone on auditory event-related potentials in schizophrenia. Int J Neuropsychopharmacol 1999;2:299-304.
52. Pekkone E, Hirvonen J, Ahveninen J, et al. Memory-based comparison process not attenuated by haloperidol: a combined MEG and EEG study. Neuroreport 2002;13:177-81.
53. Leung S, Croft R, Baldeweg T, et al. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. Psychopharmacology (Berl) 2007; 194:443-51.